NAME Dr. Daniel Carter
CANCER TYPE Neuroblastoma
INSTITUTION University of New South Wales
STATE New South Wales
GRANT TYPE $80,000

"Neuroblastoma is a deadly childhood cancer. Unfortunately current chemotherapy drugs only provide short-lived benefits and neuroblastoma often relapses. We will analyse individual cells from neuroblastoma tumours to identify the genetic mechanisms that cause tumour relapse. This will assist in development of targeted therapies for relapsed patients and improve patient survival."

Dr Daniel Carter, researcher for University of New South Wales.